BioCentury
ARTICLE | Financial News

OptiNose amends IPO

October 3, 2017 8:55 PM UTC

On Oct. 3, OptiNose Inc. (Yardley, Pa.) amended its IPO on NASDAQ and now plans to sell 6.3 million shares at $15-$17. On Sept. 18, the company proposed to raise $100 million. Jefferies, Piper Jaffray, BMO Capital Markets and RBC Capital Markets are the underwriters...

BCIQ Company Profiles

OptiNose Inc.